A proof of concept case study to investigate accelerated LIFU protocol in chronic pain and anxiety populations.
A single-arm, open label, 2 cohort (chronic pain/GAD) case study with extended (6 months) follow-up following accelerated low-intensity focused ultrasound for neuromodulation.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Low-Intensity Focused Ultrasound applied multiple times in a single study visit.
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States
Safety - monitoring of possible symptoms
Symptom monitoring before and after LIFU applications and throughout 6 months of follow-up. Each symptom is presented with a likert scale (absent, mild, moderate, severe) - along with a free response option for any symptoms not included in the list.
Time frame: Throughout study participation at multiple time points, approximately 6 months.
Changes in Chronic Pain - self report
Participants will complete the Brief Pain Inventory (BPI) at multiple time points throughout the 6 month period. This questionnaire asks participants to rate their pain on a 10 point scale (10 being the most pain).
Time frame: Multiple timepoints throughout the 6 month experimental timeframe.
Changes in Anxiety - self report
Participants will complete the Beck Anxiety Inventory (BAI) at multiple time points before and after LIFU application to track changes in anxiety throughout the 6 month timeframe. The BAI probes different symptoms of anxiety and participants rate it on a likert scale (not at all, mildly, moderately, or severely).
Time frame: Throughout the experimental timeframe, approximately 6 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.